INNOVADERM CRO IS NOW INDERO.

Our Insights

FILTER BY:

Case Study

Systemic Sclerosis Case Study

Case Study

Urticaria Case Study

Case Study

Atopic Dermatitis (AD) Rescue Case Study

Case Study

A Success Story: Pre-IND and IND Support for an Alopecia Areata Investigational Product

Case Study

Plaque Psoriasis Case Study

Case Study

Nimbus Testimonial

Case Study

“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience (…)” – An Inmagene Biopharmaceuticals Testimonial

Case Study

Success Story: Support for Vitiligo Pre-IND Submission and FDA Meeting Preparation

Case Study

Testimonial: “Thanks to Indero’s adaptive approach, we sailed through our trial with ease!”

Case Study

Indero, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study

Case Study

Generalized Pustular Psoriasis (GPP) Rescue Case Study

Case Study

Hidradenitis Suppurativa (HS) Case Study

Case Study

Palmoplantar Pustulosis (PPP) Case Study

Case Study

Notalgia Paresthetica (NP) Case Study

Case Study

Alopecia Areata (AA) Case Study

Case Study

Atopic Dermatitis (AD) Case Study

Case Study

Acne Case Study

FILTER BY:

News

Dr. Robert Bissonnette to Present at AAD Innovation Academy 2026

News

See You at EULAR 2026 in London

News

Meet Our Team at the European Dermatology Drug Development Summit in Amsterdam

News

Indero is attending the 2026 SID Annual Meeting in Chicago!

News

Sustained Prominence: Indero Presents High‑Impact Clinical Research at AAD Late‑Breaking Sessions

News

Indero to Participate in the DIF Entrepreneur Bootcamp in Denver

News

Indero’s Breakfast Event at the AAD 2026: Navigating Placebo Response in Dermatology Trials

News

Indero Contributes to New British Journal of Dermatology Publication Exploring the Gut–Skin Connection in Chronic Hand Eczema

News

Join Us at AAD 2026 in Denver, Booth #3945!

FILTER BY:

Post

Eureka! Insights from EULAR 2026, Rheumatology’s Euro-Bonanza

Post

What Placebo Response Data in Atopic Dermatitis Trials are Actually Telling Us

Post

Placebo Response in Clinical Trials for Hidradenitis Suppurativa

Post

Reflections on SID 2026: Advances in Dermatology Research

Post

Your AAD 2026 Roadmap: 10 High-Impact Sessions to Prioritize in Denver

Post

Building Momentum in Clinical Trial Start‑Up

Post

Top Rheumatology Conferences to Attend

Post

The Strategic Power of Public Relations in Scientific and Technical Industries

Post

Rethinking CRA Oversight

FILTER BY:

White Paper

Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

White Paper

Leveraging Technology in Phase I Clinical Trials

FILTER BY:

Webinar

Navigating Placebo Response in Dermatology Trials – AAD Breakfast Event

Webinar

Challenges of Managing Clinical Trials in Urticaria

Webinar

Updates on Chronic Spontaneous Urticaria

Webinar

Updates on Chronic Inducible Urticaria

Webinar

Exploring the Intersections: Dermatology and Rheumatology Insights

Webinar

Diving into the World of Adaptive Study Design – The Intersection of Statistics and Dermatology in Clinical Trials

Webinar

In-Person Breakfast Event at the AAD – Exploring the Innovation and Research on Alopecia Areata

Webinar

“Clinical Development Strategy that Patients Need and Investors Want” by Dr. Jasmina Jankicevic

Webinar

On the Edge of Dermatology Early Phase Trials

FILTER BY:

One-Pager

Rheumatology Trial Readiness Checklist

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.